NHS England

Commissioning recommendations for medical retinal vascular medicines following the national procurement for anti-vascular endothelial growth factors (VEGFs) and intravitreal ...

Ophthalmology is the highest volume outpatient specialty within the NHS and the medicines used for medical retinal vascular conditions account for some of the highest cost and volume treatments used ...
Healio

Axpaxli meets superiority primary endpoint vs. aflibercept in wet AMD

Please provide your email address to receive an email when new articles are posted on . The tyrosine kinase inhibitor maintained vision at week 36 in the SOL-1 trial. Axpaxli demonstrated positive ...
U.S. News & World Report

Brain Implant Can Read Movement Of Parkinson's Patients, Opening Door To More Effective Treatment

Brain Implant Can Read Movement Of Parkinson's Patients, Opening Door To More Effective Treatment By Dennis Thompson HealthDay ReporterTUESDAY, Feb. 17, 2026 (HealthDay News) — A new advance might ...
FiercePharma

Ocular Therapeutix eyes FDA filing with ph. 3 wet AMD win over Eylea, but investors balk

Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched position in wet age-related macular degeneration (AMD) with investigational ...